Combined plasma NGAL, Cystatin C, and NT-proBNP values above basal levels could significantly improve the predictive accuracy of the diagnosis of CRS in ADHF or AHF patients (Phan, 2021; Song et al., 2021). This evidence concerns the gene CST3 and congenital rubella syndrome.